Surrey Heartlands

Joint Formulary & PAD

Tenecteplase - Thrombolysis

You are here : Home > Formulary Search > Tenecteplase - Thrombolysis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
10,000 unit injection - licensed for acute MI

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tenecteplase
Indication :
Thrombolysis
Group Name :
Keywords :
fibrinolytics, thrombolytic therapy, acute myocardial infarction, MI
Brand Names Include :
Metalyse
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Tenecteplase is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Thrombolysis.

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.